Beth Hecht is a director of Iterum Therapeutics Plc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Xeris Biopharma Holdings, Inc.
31 Jan 24
4
Iterum Therapeutics plc
15 Jun 23
4
Xeris Biopharma Holdings, Inc.
1 Feb 23
4
Iterum Therapeutics plc
24 Jun 22
4
Iterum Therapeutics plc
17 Jun 22
4
Iterum Therapeutics plc
22 Mar 22
4
Xeris Biopharma Holdings, Inc.
5 Jan 22
4
Xeris Biopharma Holdings, Inc.
5 Oct 21
4
XERIS PHARMACEUTICALS INC
5 Oct 21
3
Xeris Biopharma Holdings, Inc.
5 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 750,000 | 0.00 | 1,554,968 |
15 Jun 23 | ITRM Iterum Therapeutics | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 15,853 | 0.00 | 18,839 |
15 Jun 23 | ITRM Iterum Therapeutics | Restricted Share Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 15,853 | 0.00 | 0 |
31 Jan 23 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 350,000 | 0.00 | 797,758 |